255 related articles for article (PubMed ID: 32297896)
1. Matrix density drives 3D organotypic lymphatic vessel activation in a microfluidic model of the breast tumor microenvironment.
Lugo-Cintrón KM; Ayuso JM; White BR; Harari PM; Ponik SM; Beebe DJ; Gong MM; Virumbrales-Muñoz M
Lab Chip; 2020 May; 20(9):1586-1600. PubMed ID: 32297896
[TBL] [Abstract][Full Text] [Related]
2. Human organotypic lymphatic vessel model elucidates microenvironment-dependent signaling and barrier function.
Gong MM; Lugo-Cintron KM; White BR; Kerr SC; Harari PM; Beebe DJ
Biomaterials; 2019 Sep; 214():119225. PubMed ID: 31154151
[TBL] [Abstract][Full Text] [Related]
3. YAP1/Piezo1 involve in the dynamic changes of lymphatic vessels in UVR-induced photoaging progress to squamous cell carcinoma.
Yang YL; Zhou C; Chen Q; Shen SZ; Li JD; Wang XL; Wang PR
J Transl Med; 2023 Nov; 21(1):820. PubMed ID: 37974224
[TBL] [Abstract][Full Text] [Related]
4. Novel mechanism for OSM-promoted extracellular matrix remodeling in breast cancer: LOXL2 upregulation and subsequent ECM alignment.
Dinca SC; Greiner D; Weidenfeld K; Bond L; Barkan D; Jorcyk CL
Breast Cancer Res; 2021 May; 23(1):56. PubMed ID: 34011405
[TBL] [Abstract][Full Text] [Related]
5. Stiff collagen matrices increase tumorigenic prolactin signaling in breast cancer cells.
Barcus CE; Keely PJ; Eliceiri KW; Schuler LA
J Biol Chem; 2013 May; 288(18):12722-32. PubMed ID: 23530035
[TBL] [Abstract][Full Text] [Related]
6. In vivo "MRI phenotyping" reveals changes in extracellular matrix transport and vascularization that mediate VEGF-driven increase in breast cancer metastasis.
Pathak AP; McNutt S; Shah T; Wildes F; Raman V; Bhujwalla ZM
PLoS One; 2013; 8(5):e63146. PubMed ID: 23650550
[TBL] [Abstract][Full Text] [Related]
7. Dense collagen-I matrices enhance pro-tumorigenic estrogen-prolactin crosstalk in MCF-7 and T47D breast cancer cells.
Barcus CE; Holt EC; Keely PJ; Eliceiri KW; Schuler LA
PLoS One; 2015; 10(1):e0116891. PubMed ID: 25607819
[TBL] [Abstract][Full Text] [Related]
8. In vitro vascularized tumor platform for modeling tumor-vasculature interactions of inflammatory breast cancer.
Gadde M; Phillips C; Ghousifam N; Sorace AG; Wong E; Krishnamurthy S; Syed A; Rahal O; Yankeelov TE; Woodward WA; Rylander MN
Biotechnol Bioeng; 2020 Nov; 117(11):3572-3590. PubMed ID: 32648934
[TBL] [Abstract][Full Text] [Related]
9. Macphatics and PoEMs in Postpartum Mammary Development and Tumor Progression.
Elder AM; Stoller AR; Black SA; Lyons TR
J Mammary Gland Biol Neoplasia; 2020 Jun; 25(2):103-113. PubMed ID: 32535810
[TBL] [Abstract][Full Text] [Related]
10. JNK1 stress signaling is hyper-activated in high breast density and the tumor stroma: connecting fibrosis, inflammation, and stemness for cancer prevention.
Lisanti MP; Tsirigos A; Pavlides S; Reeves KJ; Peiris-Pagès M; Chadwick AL; Sanchez-Alvarez R; Lamb R; Howell A; Martinez-Outschoorn UE; Sotgia F
Cell Cycle; 2014; 13(4):580-99. PubMed ID: 24434780
[TBL] [Abstract][Full Text] [Related]
11. In vitro modeling of solid tumor interactions with perfused blood vessels.
Kwak TJ; Lee E
Sci Rep; 2020 Nov; 10(1):20142. PubMed ID: 33214583
[TBL] [Abstract][Full Text] [Related]
12. Prolactin signaling through focal adhesion complexes is amplified by stiff extracellular matrices in breast cancer cells.
Barcus CE; Keely PJ; Eliceiri KW; Schuler LA
Oncotarget; 2016 Jul; 7(30):48093-48106. PubMed ID: 27344177
[TBL] [Abstract][Full Text] [Related]
13. Collagen Matrix Density Drives the Metabolic Shift in Breast Cancer Cells.
Morris BA; Burkel B; Ponik SM; Fan J; Condeelis JS; Aguirre-Ghiso JA; Castracane J; Denu JM; Keely PJ
EBioMedicine; 2016 Nov; 13():146-156. PubMed ID: 27743905
[TBL] [Abstract][Full Text] [Related]
14. An Engineered Breast Cancer Model on a Chip to Replicate ECM-Activation In Vitro during Tumor Progression.
Gioiella F; Urciuolo F; Imparato G; Brancato V; Netti PA
Adv Healthc Mater; 2016 Dec; 5(23):3074-3084. PubMed ID: 27925458
[TBL] [Abstract][Full Text] [Related]
15. Human Tumor-Lymphatic Microfluidic Model Reveals Differential Conditioning of Lymphatic Vessels by Breast Cancer Cells.
Ayuso JM; Gong MM; Skala MC; Harari PM; Beebe DJ
Adv Healthc Mater; 2020 Feb; 9(3):e1900925. PubMed ID: 31894641
[TBL] [Abstract][Full Text] [Related]
16. A novel method to understand tumor cell invasion: integrating extracellular matrix mimicking layers in microfluidic chips by "selective curing".
Eslami Amirabadi H; SahebAli S; Frimat JP; Luttge R; den Toonder JMJ
Biomed Microdevices; 2017 Oct; 19(4):92. PubMed ID: 29038872
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer cell behaviors on staged tumorigenesis-mimicking matrices derived from tumor cells at various malignant stages.
Hoshiba T; Tanaka M
Biochem Biophys Res Commun; 2013 Sep; 439(2):291-6. PubMed ID: 23978418
[TBL] [Abstract][Full Text] [Related]
18. ELK3 expressed in lymphatic endothelial cells promotes breast cancer progression and metastasis through exosomal miRNAs.
Kim KS; Park JI; Oh N; Cho HJ; Park JH; Park KS
Sci Rep; 2019 Jun; 9(1):8418. PubMed ID: 31182803
[TBL] [Abstract][Full Text] [Related]
19. Expression and clinical significance of extracellular matrix protein 1 and vascular endothelial growth factor-C in lymphatic metastasis of human breast cancer.
Wu QW; She HQ; Liang J; Huang YF; Yang QM; Yang QL; Zhang ZM
BMC Cancer; 2012 Jan; 12():47. PubMed ID: 22284579
[TBL] [Abstract][Full Text] [Related]
20. Extracellular Matrix Derived from High Metastatic Human Breast Cancer Triggers Epithelial-Mesenchymal Transition in Epithelial Breast Cancer Cells through αvβ3 Integrin.
M Brandão-Costa R; Helal-Neto E; M Vieira A; Barcellos-de-Souza P; Morgado-Diaz J; Barja-Fidalgo C
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32340328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
